Results 181 to 190 of about 666,121 (300)

Deciphering diverse cell‐death patterns to predict the prognosis and potential therapy target of hepatocellular carcinoma patients

open access: yesVIEW, EarlyView.
Abstract Ninety percent of all primary liver malignancies are hepatocellular carcinomas (HCC), making liver cancer the third most common cause of cancer‐associated mortality. Different patterns of programmed cell death (PCD) are crucial for the survival of tumors, and they might serve as a prognostic marker for HCC.
Lin Ding   +10 more
wiley   +1 more source

Diagnostic value of plasma TFF3‐centered combined biomarker panel in early gastrointestinal cancer

open access: yesVIEW, EarlyView.
In this study, a retrospective cohort was established, including gastrointestinal cancer, non‐GI cancer, and healthy controls. TFF3, CEA, and gastric function indicators were detected. TFF3 showed significantly better diagnostic performance compared with conventional gastrointestinal indicators in gastric cancer, and compared with CEA in ...
Yizhou Huang   +7 more
wiley   +1 more source

Prognostic Value of FST and Relevance to Immune Infiltration in Head and Neck Squamous Cell Carcinoma

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Immunotherapy response rates in head and neck squamous cell carcinoma (HNSCC) are limited by multiple factors. Tumor cell‐derived follistatin (FST) has been linked to immunotherapy resistance, but the underlying mechanisms remain poorly understood. This study aimed to investigate the prognostic value of FST and its associations with
Pan Song   +6 more
wiley   +1 more source

Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes

open access: yesWorld Journal of Surgery, EarlyView.
Prehabilitation (prehab) aims to prepare patients for treatment by lowering risk, promoting fitness, and improving outcomes—yet prehab's exact merit is controversial, not least because of conflicting evidence related to study heterogeneity, equity of access, and protocol uniformity.
Geraint L. Herbert   +20 more
wiley   +1 more source

Osteoblastic skeletal metastases mimicking high-bone-turnover metabolic bone disease in gastric adenocarcinoma. [PDF]

open access: yesJCEM Case Rep
Madala SM   +5 more
europepmc   +1 more source

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue   +3 more
wiley   +1 more source

Post-neoadjuvant therapy lymph node response in patients with gastric adenocarcinoma. [PDF]

open access: yesArq Bras Cir Dig
Ishak G   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy